Table 3.
Model for the Physical Subscale of the Functional Assessment of Cancer Therapy–General
| Baseline |
Model A |
Model B |
|
|---|---|---|---|
| Coefficient (SE) | Coefficient (SE) | Coefficient (SE) | |
| Fixed effects | |||
| Baseline | 18.75 (0.88) | 18.75 (0.88)a | 18.75 (0.88)a |
| Uncertainty—T1 | – | – | 0.23 (0.02)a |
| Time 1-time 2 | 1.45 (0.37) | 1.45 (0.37)b | 1.45 (0.37)b |
| Time 2-time 3 | 1.63 (.29) | 1.51 (0.56) | 1.53 (0.83) |
| Uncertainty—T2 | – | 0.09 (0.14)a | 0.05 (0.18)b |
| Variance components | |||
| Level 1: within-person | 8.50 | 8.69 | 8.30 |
| Level 2: baseline | 18.75 | 18.75 | 12.35 |
| Level 2: slope at T2 | 8.41 | 0.75 | 0.78 |
| Deviance (DF) | 471.91 (7) | 456.11 (8) | 441.08 |
| ΔDeviance (df) | – | 15.80 (1), P < .000 | 15.03 (1), P < .001 |
a
P < .01.
b
P < .05.